Showing results (1131-1140 of 1,628) with videos related to
Sort By:
Pageof 163
The International Journal of Biological Markers|December 22, 2021
Clinicopathological significance of DAPK gene promoter hypermethylation in non-small cell lung cancer: A meta-analysisZhimao Chen, Yu Fan, Xiangzheng Liu, et al.The International Journal of Biological Markers|January 4, 2022
Meta-analysis of the diagnostic performance of serum carbohydrate antigen 19-9 for the detection of gallbladder cancerXiaolei ZhouThe International Journal of Biological Markers|September 27, 2021
Serum epithelial membrane protein 1 serves as a feasible biomarker in extrahepatic cholangiocarcinomaXiang Li, Lang Yan, Hao XueThe International Journal of Biological Markers|February 24, 2022
Who with suspected prostate cancer can benefit from Proclarix after multiparametric magnetic resonance imaging?Juan Morote, Miriam Campistol, Lucas Regis, et al.The International Journal of Biological Markers|February 14, 2022
Estimation of associations between MMP9 gene polymorphisms and breast cancer: Evidence from a meta-analysisCunye Yan, Chenyu Sun, Dengwei Lu, et al.The International Journal of Biological Markers|May 4, 2019
The serum level of CC chemokine ligand 18 correlates with the prognosis of non-small cell lung cancerHui Huang, Jing Li, Wen-Jia Hu, et al.The International Journal of Biological Markers|May 16, 2019
Predictive significance of CYFRA21-1, squamous cell carcinoma antigen and carcinoembryonic antigen for lymph node metastasis in patients with esophageal squamous cancerXinyu Mei, Xiaodong Zhu, Lei Zuo, et al.The International Journal of Biological Markers|April 13, 2019
Prognostic markers affecting the early recurrence of hepatocellular carcinoma with liver cirrhosis after curative resectionWan-Joon Kim, Tae-Wan Lim, Pyoung-Jae Park, et al.The International Journal of Biological Markers|May 2, 2019
iTRAQ-based proteomics reveals SOD2 as a potential salivary biomarker in liver cancerFeng Ding, Kehuan Sun, Ningning Sun, et al.The International Journal of Biological Markers|January 24, 2022
A functional polymorphism within the distal promoter of RUNX3 confers risk of colorectal cancerHuiping Wang, Jin Wang, Danhua Li, et al.Pageof 163